Adicet Bio’s $100.6 Million Rights Offering

Goodwin Procter advised Adicet Bio, Inc. on the deal.Adicet Bio, Inc. (Nasdaq: ACET) announced its underwritten public offering of 7,187,500 shares of its common stock, including the…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now